Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXAZOSIN Cause Chronic obstructive pulmonary disease? 76 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Chronic obstructive pulmonary disease have been filed in association with DOXAZOSIN (Doxazosin). This represents 1.6% of all adverse event reports for DOXAZOSIN.

76
Reports of Chronic obstructive pulmonary disease with DOXAZOSIN
1.6%
of all DOXAZOSIN reports
3
Deaths
49
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From DOXAZOSIN?

Of the 76 reports, 3 (3.9%) resulted in death, 49 (64.5%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXAZOSIN. However, 76 reports have been filed with the FAERS database.

What Other Side Effects Does DOXAZOSIN Cause?

Asthma (413) Dyspnoea (393) Hypotension (385) Drug ineffective (367) Productive cough (350) Syncope (343) Dizziness (341) Wheezing (328) Condition aggravated (325) Thrombosis (274)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which DOXAZOSIN Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

DOXAZOSIN vs DOXAZOSIN\DOXAZOSIN DOXAZOSIN vs DOXEPIN DOXAZOSIN vs DOXERCALCIFEROL DOXAZOSIN vs DOXIFLURIDINE DOXAZOSIN vs DOXORUBICIN

Related Pages

DOXAZOSIN Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease DOXAZOSIN Demographics